Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Nolan John; Wijaya Audrey Rachel; Lianto Agatha Nadya; Saraswati Made Ratna

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Medical Reviews Year:2020 | Volume:7 | Issue:1 Page(s): 11-14

Download Full-Text

View:

123

Download:

Cites:

Information Journal Paper

Title

Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM)

Author(s)

Nolan John | Wijaya Audrey Rachel | Lianto Agatha Nadya | Saraswati Made Ratna | Issue Writer Certificate

Keywords

Type 1 Diabetes Mellitus

Embryonic Stem Cells

Fibroblast Growth Factor-2

Abstract

Type 1 Diabetes Mellitus (T1DM) is an autoimmune disorder which results in the INS pancreatic β-cell destruction and contributes to around 5 to 10% of all diabetes mellitus cases, especially in children. At the moment, the only treatment for T1DM is by insulin injection, which is injected in order to prevent the complication of T1DM. However, several studies have shown that combination between Embryonic Stem Cells (ESCs) and the Fibroblast Growth Factor 2 (FGF-2) may be a successful modality to treat T1DM. Actually, the ESCs may become the potential therapy in treating T1DM.

Cites

No record.

References

Cite

APA: Copy

Nolan, John, Wijaya, Audrey Rachel, Lianto, Agatha Nadya, & Saraswati, Made Ratna. (2020). Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM). INTERNATIONAL JOURNAL OF MEDICAL REVIEWS, 7(1), 11-14. SID. https://sid.ir/paper/754077/en

Vancouver: Copy

Nolan John, Wijaya Audrey Rachel, Lianto Agatha Nadya, Saraswati Made Ratna. Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM). INTERNATIONAL JOURNAL OF MEDICAL REVIEWS[Internet]. 2020;7(1):11-14. Available from: https://sid.ir/paper/754077/en

IEEE: Copy

John Nolan, Audrey Rachel Wijaya, Agatha Nadya Lianto, and Made Ratna Saraswati, “Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM),” INTERNATIONAL JOURNAL OF MEDICAL REVIEWS, vol. 7, no. 1, pp. 11–14, 2020, [Online]. Available: https://sid.ir/paper/754077/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops